The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
43
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.EBI
Mcgill University
24
Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines.EBI
Merck Research Laboratories
1
 
Inhibition of prolidase by phosphoenolpyruvate is biphasic. avoidance of endogenous-metabolite inactivation by cooperativity within an enzyme dimerEBI
TBA
5
 
Peptide mimics of glycylproline as inhibitors of prolidaseEBI
TBA
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.EBI
Johann Wolfgang Goethe University
6
Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development.EBI
Universita "Gabriele d'Annunzio" Chieti - Pescara
44
Optimized M24B Aminopeptidase Inhibitors for CARD8 Inflammasome Activation.EBI
Memorial Sloan Kettering Cancer Center
40
Potent and selective proline derived dipeptidyl peptidase IV inhibitors.EBI
Merck
13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.EBI
Pharmacia and Upjohn
44
Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors.BDB
Pfizer